← Browse by Condition
Medical Condition

squamous cell esophageal carcinoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT05357846 Phase 3
Recruiting

PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally Advanced ESCC (NEOCRTEC2101)

Enrollment
422 pts
Location
China
Sponsor
Sun Yat-sen University
View Trial →